The Potential of Flavonoids and Flavonoid Metabolites in the Treatment of Neurodegenerative Pathology in Disorders of Cognitive Decline
- PMID: 36978911
- PMCID: PMC10045397
- DOI: 10.3390/antiox12030663
The Potential of Flavonoids and Flavonoid Metabolites in the Treatment of Neurodegenerative Pathology in Disorders of Cognitive Decline
Abstract
Flavonoids are a biodiverse family of dietary compounds that have antioxidant, anti-inflammatory, antiviral, and antibacterial cell protective profiles. They have received considerable attention as potential therapeutic agents in biomedicine and have been widely used in traditional complimentary medicine for generations. Such complimentary medical herbal formulations are extremely complex mixtures of many pharmacologically active compounds that provide a therapeutic outcome through a network pharmacological effects of considerable complexity. Methods are emerging to determine the active components used in complimentary medicine and their therapeutic targets and to decipher the complexities of how network pharmacology provides such therapeutic effects. The gut microbiome has important roles to play in the generation of bioactive flavonoid metabolites retaining or exceeding the antioxidative and anti-inflammatory properties of the intact flavonoid and, in some cases, new antitumor and antineurodegenerative bioactivities. Certain food items have been identified with high prebiotic profiles suggesting that neutraceutical supplementation may be beneficially employed to preserve a healthy population of bacterial symbiont species and minimize the establishment of harmful pathogenic organisms. Gut health is an important consideration effecting the overall health and wellbeing of linked organ systems. Bioconversion of dietary flavonoid components in the gut generates therapeutic metabolites that can also be transported by the vagus nerve and systemic circulation to brain cell populations to exert a beneficial effect. This is particularly important in a number of neurological disorders (autism, bipolar disorder, AD, PD) characterized by effects on moods, resulting in depression and anxiety, impaired motor function, and long-term cognitive decline. Native flavonoids have many beneficial properties in the alleviation of inflammation in tissues, however, concerns have been raised that therapeutic levels of flavonoids may not be achieved, thus allowing them to display optimal therapeutic effects. Dietary manipulation and vagal stimulation have both yielded beneficial responses in the treatment of autism spectrum disorders, depression, and anxiety, establishing the vagal nerve as a route of communication in the gut-brain axis with established roles in disease intervention. While a number of native flavonoids are beneficial in the treatment of neurological disorders and are known to penetrate the blood-brain barrier, microbiome-generated flavonoid metabolites (e.g., protocatechuic acid, urolithins, γ-valerolactones), which retain the antioxidant and anti-inflammatory potency of the native flavonoid in addition to bioactive properties that promote mitochondrial health and cerebrovascular microcapillary function, should also be considered as potential biotherapeutic agents. Studies are warranted to experimentally examine the efficacy of flavonoid metabolites directly, as they emerge as novel therapeutic options.
Keywords: Alzheimer’s disease; Parkinson’s disease; autism; bipolar disorder; gut-brainaxis; protocatechuic acid; therapeutic treatment of neurological disorders; urolithins; γ-valerolactones.
Conflict of interest statement
The author has no conflict to report.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10045397/bin/antioxidants-12-00663-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10045397/bin/antioxidants-12-00663-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10045397/bin/antioxidants-12-00663-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10045397/bin/antioxidants-12-00663-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10045397/bin/antioxidants-12-00663-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10045397/bin/antioxidants-12-00663-g006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10045397/bin/antioxidants-12-00663-g007.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10045397/bin/antioxidants-12-00663-g008.gif)
![Figure 9](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10045397/bin/antioxidants-12-00663-g009.gif)
![Figure 10](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10045397/bin/antioxidants-12-00663-g010.gif)
![Figure 11](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10045397/bin/antioxidants-12-00663-g011.gif)
Similar articles
-
Therapeutic Effects of Baicalin on Diseases Related to Gut-Brain Axis Dysfunctions.Molecules. 2023 Sep 7;28(18):6501. doi: 10.3390/molecules28186501. Molecules. 2023. PMID: 37764277 Free PMC article. Review.
-
Natural and Semi-Synthetic Flavonoid Anti-SARS-CoV-2 Agents for the Treatment of Long COVID-19 Disease and Neurodegenerative Disorders of Cognitive Decline.Front Biosci (Elite Ed). 2022 Oct 9;14(4):27. doi: 10.31083/j.fbe1404027. Front Biosci (Elite Ed). 2022. PMID: 36575843 Review.
-
Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.J Food Biochem. 2022 Dec;46(12):e14415. doi: 10.1111/jfbc.14415. Epub 2022 Sep 15. J Food Biochem. 2022. PMID: 36106706 Review.
-
Enhancing the Cognitive Effects of Flavonoids With Physical Activity: Is There a Case for the Gut Microbiome?Front Neurosci. 2022 Feb 22;16:833202. doi: 10.3389/fnins.2022.833202. eCollection 2022. Front Neurosci. 2022. PMID: 35273477 Free PMC article. Review.
-
Polyphenols in Alzheimer's Disease and in the Gut-Brain Axis.Microorganisms. 2020 Jan 31;8(2):199. doi: 10.3390/microorganisms8020199. Microorganisms. 2020. PMID: 32023969 Free PMC article. Review.
Cited by
-
Association between Flavonoid Intake and Cognitive Executive Function among African American and White Adults in the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) Study.Nutrients. 2024 Apr 30;16(9):1360. doi: 10.3390/nu16091360. Nutrients. 2024. PMID: 38732605 Free PMC article.
-
Apigenin Alleviates Autistic-like Stereotyped Repetitive Behaviors and Mitigates Brain Oxidative Stress in Mice.Pharmaceuticals (Basel). 2024 Apr 9;17(4):482. doi: 10.3390/ph17040482. Pharmaceuticals (Basel). 2024. PMID: 38675442 Free PMC article.
-
Hormetic Nutrition and Redox Regulation in Gut-Brain Axis Disorders.Antioxidants (Basel). 2024 Apr 18;13(4):484. doi: 10.3390/antiox13040484. Antioxidants (Basel). 2024. PMID: 38671931 Free PMC article. Review.
-
Gardenin A treatment attenuates inflammatory markers, synuclein pathology and deficits in tyrosine hydroxylase expression and improves cognitive and motor function in A53T-α-syn mice.Biomed Pharmacother. 2024 Apr;173:116370. doi: 10.1016/j.biopha.2024.116370. Epub 2024 Mar 8. Biomed Pharmacother. 2024. PMID: 38458012 Free PMC article.
-
The possible role of gut microbiota dysbiosis in the pathophysiology of delirium in older persons.Microbiome Res Rep. 2023 May 26;2(3):19. doi: 10.20517/mrr.2023.15. eCollection 2023. Microbiome Res Rep. 2023. PMID: 38046817 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources